We can highlight the next thriving fund investment areas, such as Medical, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Inotrem. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The important activity for fund was in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the BioMed Invest, startups are often financed by Sofinnova Partners, BioMedPartners, Andera Partners. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, Morningside Group, Invus.
The overall number of key employees were 1.
|Argosy Private Equity||Pennsylvania, United States, Wayne|
|Autonomous Ventures||Michigan, North Dakota, United States|
|Beijing Hejun Consulting||Beijing, Beijing, China|
|Beijing Senshi Touzi Guanli Co., Ltd||Beijing, China, Haidian|
|Chimera Partners||England, London, United Kingdom|
|Cooper Hill Partners||New York, New York, United States|
|Dunjun Zichan||China, Hangzhou, Zhejiang|
|Extreme Venture Partners||Canada, Ontario, Toronto|
|Kendall Family Foundation||Boston, Massachusetts, United States|
|Mineworkers Investment||Gauteng, Johannesburg, South Africa|
|Nicola Wealth Management||British Columbia, Canada, Vancouver|
|Thomson multimedia||Dallas, Texas, United States|
|Trog Hawley Capital||Florida, United States, West Palm Beach|
|Value Partners||China, Hong Kong, Hong Kong Island|
|Xiaomi Industry Fund||-|
|$46M||12 Sep 2019||Ile-de-France|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.